Prostate specific antigen density. Is there a role for this parameter when screening for prostate cancer?

Prostate Cancer and Prostatic Diseases

Volumn 4, Issue 3, 2001, Pages 146-149

  Lujan, M ^a   Paez, A ^a   Llanes, L ^a   Miravalles, E ^a   Berenguer, A ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Diagnosis; Prostate specific antigen; Prostatic hyperplasia; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; HUMAN; INTESTINE EXAMINATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0034804475     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500509     Document Type: Article

References (19)

1. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
2. Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges
3. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
4. Prostate specific antigen density: A means of distinguishing benign prostatic hyperplasia and prostate cancer
5. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen
6. PSA density (PSAD). Role in patient evaluation and management
7. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma
8. Prostate specific antigen density in patients with histologically proven prostate carcinoma
9. Prostate-specific antigen density: A means to enhance detection of prostate cancer
10. Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels
11. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves
12. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
13. The value of prostate specific antigen (PSA) density and free: Total PSA ratio in selecting patients with a normal digital rectal examination and intermediate total PSA levels for further investigation
14. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels
15. The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma
16. Determination of prostate volume with transrectal US for cancer screening. Accuracy of in vitro and in vivo techniques
17. Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostate-specific antigen velocity
18. Prostate specific antigen variation in patients without clinically evident prostate cancer
19. Prostate specific antigen adjusted for transition zone volume: The most powerful method for detecting prostate carcinoma